Cell Line Development and Vector Selection

Get In Touch

Early decisions around cell line development and vector selection are critical as these are the foundation of your product. We’ll ensure you manage your risks and maximize your opportunity.

 

Committing to cell line development and vector selection early in development is critical as these elements are very difficult to change later. Our experts can advise on the selection, design and sourcing of producer cells to avoid issues down the line. We’ll help to minimize any delays and risks in clinical development, and ensure your choices stand up to due diligence by potential investors.

 

Ensuring you build from the strongest foundations

 

Our consultants are highly experienced in the development of a wide range of biopharmaceuticals, from concept to marketing approval. This expertise encompasses potential pitfalls and how to avoid them, along with the likely response of regulators.

We’ll help you make the best decisions from the outset, avoiding potential issues such as:

  • Regulatory objections, requiring reengineering
  • The inability to scale/adapt for commercial manufacture
  • Inconsistencies in manufacture

 

Get In Touch

Insights Hub

Sharing insights, questioning norms, asking the right questions - we'll never lose sight of what you're striving for. Our insight and expertise will help you bring the most innovative therapies within reach of patients around the world.
Placeholder Image
28.06.23
Steve

Cell & Gene Therapy: Maximizing Commercialization Potential

How to Navigate the Less Obvious Barriers to Brining Advanced & Highly Targeted Treatments to

Start a conversation today

If you’re developing something truly ground-breaking, Biopharma Excellence is the nearest resource you’ll find to someone who’s been there before.

Socials:









    We are now Cencora PharmaLex 

    PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

    Know more